Biokinetics of subacutely co-inhaled same size gold and silver nanoparticles.
Biokinetics
Clearance
Co-inhalation exposure
Elimination
Gold nanoparticles
Silver nanoparticles
Tissue distribution
Toxicokinetics
Translocation
Journal
Particle and fibre toxicology
ISSN: 1743-8977
Titre abrégé: Part Fibre Toxicol
Pays: England
ID NLM: 101236354
Informations de publication
Date de publication:
31 03 2023
31 03 2023
Historique:
received:
30
09
2022
accepted:
24
01
2023
medline:
3
4
2023
entrez:
30
3
2023
pubmed:
31
3
2023
Statut:
epublish
Résumé
Toxicokinetics of nanomaterials, including studies on the absorption, distribution, metabolism, and elimination of nanomaterials, are essential in assessing their potential health effects. The fate of nanomaterials after inhalation exposure to multiple nanomaterials is not clearly understood. Male Sprague-Dawley rats were exposed to similar sizes of silver nanoparticles (AgNPs, 10.86 nm) and gold nanoparticles (AuNPs, 10.82 nm) for 28 days (6-h/day, 5-days/week for four weeks) either with separate NP inhalation exposures or with combined co-exposure in a nose-only inhalation system. Mass concentrations sampled from the breathing zone were AuNP 19.34 ± 2.55 μg/m AuNP was translocated to the extrapulmonary organs, including the liver, kidney, spleen, testis, epididymis, olfactory bulb, hilar and brachial lymph nodes, and brain after subacute inhalation and showed biopersistence regardless of AuNP single exposure or AuNP + AgNP co-exposure, showing similar elimination half-time. In contrast, Ag was translocated to the tissues and rapidly eliminated from the tissues regardless of AuNP co-exposure. Ag was continually accumulated in the olfactory bulb and brain and persistent until PEO-28. Our co-exposure study of AuNP and AgNP indicated that soluble AgNP and insoluble AuNP translocated differently, showing soluble AgNP could be dissolved into Ag ion to translocate to the extrapulmonary organs and rapidly removed from most organs except the brain and olfactory bulb. Insoluble AuNPs were continually translocated to the extrapulmonary organs, and they were not eliminated rapidly.
Sections du résumé
BACKGROUND
Toxicokinetics of nanomaterials, including studies on the absorption, distribution, metabolism, and elimination of nanomaterials, are essential in assessing their potential health effects. The fate of nanomaterials after inhalation exposure to multiple nanomaterials is not clearly understood.
METHODS
Male Sprague-Dawley rats were exposed to similar sizes of silver nanoparticles (AgNPs, 10.86 nm) and gold nanoparticles (AuNPs, 10.82 nm) for 28 days (6-h/day, 5-days/week for four weeks) either with separate NP inhalation exposures or with combined co-exposure in a nose-only inhalation system. Mass concentrations sampled from the breathing zone were AuNP 19.34 ± 2.55 μg/m
RESULTS
AuNP was translocated to the extrapulmonary organs, including the liver, kidney, spleen, testis, epididymis, olfactory bulb, hilar and brachial lymph nodes, and brain after subacute inhalation and showed biopersistence regardless of AuNP single exposure or AuNP + AgNP co-exposure, showing similar elimination half-time. In contrast, Ag was translocated to the tissues and rapidly eliminated from the tissues regardless of AuNP co-exposure. Ag was continually accumulated in the olfactory bulb and brain and persistent until PEO-28.
CONCLUSION
Our co-exposure study of AuNP and AgNP indicated that soluble AgNP and insoluble AuNP translocated differently, showing soluble AgNP could be dissolved into Ag ion to translocate to the extrapulmonary organs and rapidly removed from most organs except the brain and olfactory bulb. Insoluble AuNPs were continually translocated to the extrapulmonary organs, and they were not eliminated rapidly.
Identifiants
pubmed: 36997977
doi: 10.1186/s12989-023-00515-z
pii: 10.1186/s12989-023-00515-z
pmc: PMC10064767
doi:
Substances chimiques
Gold
7440-57-5
Silver
3M4G523W1G
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
9Informations de copyright
© 2023. The Author(s).
Références
Part Fibre Toxicol. 2021 Jan 21;18(1):5
pubmed: 33478543
Nanotoxicology. 2013 Mar;7(2):169-80
pubmed: 22264098
Part Fibre Toxicol. 2020 Jun 5;17(1):21
pubmed: 32503677
Arch Toxicol. 2018 Apr;92(4):1393-1405
pubmed: 29450565
Inhal Toxicol. 2007 Aug;19(10):857-71
pubmed: 17687717
Toxicol Sci. 2015 Apr;144(2):366-81
pubmed: 25577195
Environ Health Perspect. 2005 Jul;113(7):823-39
pubmed: 16002369
Arch Toxicol. 2015 Jul;89(7):1083-94
pubmed: 24935253
Part Fibre Toxicol. 2013 Aug 01;10:36
pubmed: 24059869
Part Fibre Toxicol. 2011 May 14;8:16
pubmed: 21569586
Inhal Toxicol. 2006 Sep;18(10):733-40
pubmed: 16774862
Inhal Toxicol. 2007 Jul;19(9):745-51
pubmed: 17613082
Arch Toxicol. 2020 Mar;94(3):773-784
pubmed: 32157349
Respir Res. 2016 Jul 19;17(1):85
pubmed: 27435725
ACS Nano. 2018 Aug 28;12(8):7771-7790
pubmed: 30085651
Toxicol Sci. 2009 Apr;108(2):452-61
pubmed: 19033393
Part Fibre Toxicol. 2014 Sep 17;11:49
pubmed: 25227272